Clinical Trial Update: Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients [Phase 4]

View source ↗

Summary

This document reports an ongoing Phase 4 clinical trial evaluating the efficacy and safety of combining Dupilumab with Tofacitinib in adults with moderate-to-se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Atopic Dermatitis | Phase 4 | Status: NOT_YET_RECRUITING